SI-BONE Inc. (SIBN) Tops Q2 EPS by 10c; Raises FY23 Revenue Guidance

SI-BONE Inc. (NASDAQ: SIBN) reported Q2 EPS of ($0.30), $0.10 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $33.3 million versus the consensus estimate of $31.04 million.

GUIDANCE:

SI-BONE Inc. sees FY2023 revenue of $132-134 million, versus prior of $128-$131 million and the consensus of $130.03 million.

For earnings history and earnings-related data on SI-BONE Inc. (SIBN) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• InspireMD (NSPR) Tops Q2 EPS by 1c
• INVO Fertility (IVF) Tops Q2 EPS by 105c